Antifungal properties of a peptide derived from the signal peptide of the HIV-1 regulatory protein, Rev

FEBS Letters

Volumn 583, Issue 9, 2009, Pages 1544-1547

  Lee, Juneyoung ^a   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Antifungal peptide; Membrane active mechanism; Nuclear entry inhibitory signal peptide of Rev protein (Rev NIS)

Indexed keywords

BIS (1,3 DIBUTYLBARBITURIC ACID) TRIMETHINE OXONOL; CALCEIN; NUCLEAR ENTRY INHIBITORY SIGNAL PEPTIDE OF REV PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; REGULATOR PROTEIN; REV PROTEIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GIANT UNILAMELLAR VESICLE; HEMOLYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; LARGE UNILAMELLAR VESICLE; MEMBRANE VESICLE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; HEMOLYSIS; MALASSEZIA; MICROBIAL SENSITIVITY TESTS; PROTEIN SORTING SIGNALS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRICHOSPORON;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67349286175     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.03.063     Document Type: Article

References (32)

1. Cohen M.L. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257 (1992) 1050-1055
2. Hsu C.H., Chen C., Jou M.L., Lee A.Y., Lin Y.C., Yu Y.P., Huang W.T., and Wu S.H. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucl. Acids Res. 33 (2005) 4053-4064
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
4. Kalland K.H., Szilvay A.M., Brokstad K.A., Saetrevik W., and Haukenes G. The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol. Cell Biol. 14 (1994) 7436-7444
5. Meyer B.E., and Malim M.H. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8 (1994) 1538-1547
6. Richard N., Iacampo S., and Cochrane A. HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology 204 (1994) 123-131
7. Wolff B., Cohen G., Hauber J., Meshcheryakova D., and Rabeck C. Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Exp. Cell Res. 217 (1995) 31-41
8. Kubota S., and Pomerantz R.J. A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins. Oncogene 16 (1998) 1851-1861
9. Merrifield B. Solid phase synthesis. Science 232 (1986) 341-347
10. Jungblut P., and Thiede B. Protein identification from 2-DE gels by MALDI mass spectrometry. Mass Spectrom. Rev. 16 (1997) 145-162
11. Sung W.S., Lee I.S., and Lee D.G. Damage to the cytoplasmic membrane and cell death caused by lycopene in Candida albicans. J. Microbiol. Biotechnol. 17 (2007) 1797-1804
12. Klepser M.E., Ernst E.J., Lewis R.E., Ernst M.E., and Pfaller M.A. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42 (1998) 1207-1212
13. Sung W.S., Park S.H., and Lee D.G. Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus. FEBS Lett. 582 (2008) 2463-2466
14. Liao R.S., Rennie R.P., and Talbot J.A. Assessment of the effect of amphotericin B on the vitality of Candida albicans. Antimicrob. Agents Chemother. 43 (1999) 1034-1041
15. Sung W.S., Lee J., and Lee D.G. Fungicidal effect and the mode of action of piscidin 2 derived from hybrid striped bass. Biochem. Biophys. Res. Commun. 371 (2008) 551-555
16. Habermann E. Bee and wasp venoms. Science 177 (1972) 314-322
17. Matsuzaki K., Yoneyama S., and Miyajima K. Pore formation and translocation of melittin. Biophys. J. 73 (1997) 831-838
18. Klein R.S., Harris C.A., Small C.B., Moll B., Lesser M., and Friedland G.H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. New Engl. J. Med. 311 (1984) 354-358
19. Epps D.E., Wolfe M.L., and Groppi V. Characterization of the steady-state and dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)trimethine oxonol (Dibac4(3)) in model systems and cells. Chem. Phys. Lipids 69 (1994) 137-150
20. Bräuner T., Hülser D.F., and Strasser R.J. Comparative measurements of membrane potentials with microelectrodes and voltage-sensitive dyes. Biochim. Biophys. Acta 771 (1984) 208-216
21. Makovitzki A., and Shai Y. pH-dependent antifungal lipopeptides and their plausible mode of action. Biochemistry 44 (2005) 9775-9784
22. Evans E., and Rawicz W. Entropy-driven tension and bending elasticity in condensed-fluid membranes. Phys. Rev. Lett. 64 (1990) 2094-2097
23. Sandre O., Moreaux L., and Brochard-Wyart F. Dynamics of transient pores in stretched vesicles. Proc. Natl. Acad. Sci. USA 96 (1999) 10591-10596
24. Käs J., and Sackmann E. Shape transitions and shape stability of giant phospholipid vesicles in pure water induced by area-to-volume changes. Biophys. J. 60 (1991) 825-844
25. Farge E., and Devaux P.F. Shape changes of giant liposomes induced by an asymmetric transmembrane distribution of phospholipids. Biophys. J. 61 (1992) 347-357
26. 3+ induce shape change of giant unilamellar vesicles of phosphatidylcholine. Biochim. Biophys. Acta 1564 (2002) 173-182
27. Yamashita Y., Masum S.M., Tanaka T., and Yamazaki T.M. Shape changes of giant unilamellar vesicles of phosphatidyl-choline induced by a de novo designed peptide interacting with their membrane interface. Langmuir 18 (2002) 9638-9641
28. Saitoh A., Takiguchi K., Tanaka Y., and Hotani H. Opening-up of liposomal membranes by talin. Proc. Natl. Acad. Sci. USA 95 (1998) 1026-1031
29. 3+. Langmuir 20 (2004) 5160-5164
30. Tsumoto K., Nomura S.M., Nakatani Y., and Yoshikawa K. Giant liposomes as a biochemical reactor: transcription of DNA and transportation by laser tweezers. Langmuir 17 (2001) 7225-7228
31. Yamashita Y., Oka M., Tanaka T., and Yamazaki M. A new method for the preparation of giant liposomes in high salt concentrations and growth of protein microcrystals in them. Biochim. Biophys. Acta 1561 (2002) 129-134
32. Tamba Y., Tanaka T., Yahagi T., Yamashita Y., and Yamazaki M. Stability of giant unilamellar vesicles and large unilamellar vesicles of liquid-ordered phase membranes in the presence of Triton X-100. Biochim. Biophys. Acta 1667 (2004) 1-6